Prostate Cancer

#UCSFRadChat: Eyes on Prostate Health – Join us!

To amplify and continue the great conversation following the prostate cancer awareness event, UCSF Radiology (@UCSFimaging) will be hosting a Twitter Chat on Tuesday, September 24 from 12 – 12:45 PM PDT to coincide with Prostate Cancer Awareness Month. 

Scientists at UCSF Study Impact of 68Ga-PSMA-11 PET on Post Radical Prostatectomy (RP) Salvage Radiotherapy

Recently, scientists from the UC San Francisco Departments of Radiology and Biomedical Imaging, Urology and Radiation Oncology came together to study the impact of 68Ga-PSMA-11 PET on post radical prostatectomy (RP) salvage radiotherapy.

Researchers Assess the Accuracy of 68Ga-PSMA-11 PET in Localizing Prostate Cancer

Scientists at UCSF and UCLA designed a single-arm prospective trial on 635 patients with biochemically recurrent prostate cancer to assess the accuracy of 68Ga-PSMA-11 PET.

Results of Phase I of CTT1057 Human Clinical Trial for Prostate Cancer Now Published

Scientists at UC San Francisco have just conducted the first-in-human Phase I study of CTT1057 in patients with localized and metastatic prostate cancer.

Tackling Prostate Cancer with Innovative Imaging Techniques

For John Kurhanewicz, PhD, and other researchers at UCSF, it’s important to work in an environment that not only supports their research, but provides the funding necessary for equipment and technological resources.

Translating Advanced Prostate Cancer Research into Patient Care

John Kurhanewicz, PhD, professor in residence and director of the UCSF Body Research Interest Group, the Biomedical NMR lab, and the Kurhanewicz Laboratory, is involved in cutting-edge research to more accurately and efficiently detect and characterize prostate cancers at early stages.